Not Signed In -
CA 19-9 |
|
|
Clinical Trial: Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
This study is currently recruiting patients.
|
Purpose
A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Secondary Hyperparathyroidism Chronic Kidney Disease | Drug: Zemplar Procedure: 42 Ca carbonate absorption via single tracer method Drug: Calcijex | Phase IV |
MedlinePlus related topics: Kidney Diseases; Parathyroid Disorders
Study Type: Interventional
Study Design: Prevention, Active Control, Crossover Assignment
Official Title: A Phase IV, Single-Center, Active-Controlled Cross-Over Pilot Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
Further Study Details:
Study start: September 2004
Last follow-up: January 2005
Eligibility
Ages Eligible for Study: 20 Years and above, Genders Eligible for Study: Both
Criteria
Subject with end stage renal disease on maintenance hemodialysis three times a week for at least 2 months prior to screening
Location and Contact Information
Allam Fakhoury, Pharm.D. (847) 937-8730 Allam.Fakhoury@abbott.com
Nebraska
Creighton University, Omaha, Nebraska, 68131, United States; Recruiting
Richard Lund, M.D. 402-341-3141 rlund@creighton.ecu
Jina Bogle 402-342-4210 jbogle@creighton.edu
Richard Lund, M.D., Principal Investigator
Ann Harty, Sub-Investigator
Robert Heaney, M.D., Sub-Investigator
Jina Bogle 402-342-4210 jbogle@creighton.edu
Richard Lund, M.D., Principal Investigator
Ann Harty, Sub-Investigator
Robert Heaney, M.D., Sub-Investigator
More Information
Study ID Numbers: M01-375
Record last reviewed: January 2005
Last Updated: January 13, 2005
Record first received: December 3, 2003
ClinicalTrials.gov Identifier: NCT00073710
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: January 2005
Last Updated: January 13, 2005
Record first received: December 3, 2003
ClinicalTrials.gov Identifier: NCT00073710
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
